RBC Life Sciences
[email protected]

Basket is Empty


  Biological Terrain Assessment Results of 14 Subjects
Before and After Testing with a Supplement
Containing Silicon Bonded To Reduced Hydrogen Ions

A sample of the Ultar glacier water in Pakistan when analyzed contained 369 mg/ml of suspended rock flour and was composed of 70-80% biotite mica, 15-20% plagioclase feldspar, 5% vermiculite mica, traces of other soluble silicates, minerals (predominantly Ca+2, SO4-2, Mg+2, Na+, K+, Cl-, and HCO3-) and trace minerals [1,3]. Cooperative knowledge shared about water content from geologists, combined with the knowledge of nutritionists concerning optimum health needs has provided the impetus for upgrading the role of drinking-water in human health and longevity. A supplement has been developed which provides the qualities of glacial water containing silicate mineral crystals with a high specific surface area and ion exchange capacity [3,11].

A preliminary trial utilizing Biological Terrain Assessment (BTA), a historical method developed by Claude Vincent, a French hydrologist, and revised with modern technology, measures the pH, reduction/oxidation potential (rH2) and resistivity (r) of blood, saliva and urine of the subjects tested. BTA analysis is a non-invasive, inexpensive procedure that clinicians use to enhance their knowledge about the biochemistry of the body. Although BTA is not meant as a diagnostic tool, these parameters provide clinicians with important information concerning the effects of nutritional or therapeutic programs that tend to normalize these values important to health. A preliminary trial utilizing biological terrain assessment values provided a unique tool to assess possible short-term alterations due to the supplement.

A group of physicians and clinicians that utilize the BTA S-2000 analyzer in their clinical practices selected subjects for the trial. Signed informed consent was obtained from each individual. Two males with an average age of 49 yr. and six females with an average age of 45 yr. and who were not diagnosed with clinical pathologies, consumed 4 capsules a day on a schedule of one in the morning, two in the afternoon and one in the evening for 18 days. Three other subjects (#8, #9, and #12) who were clinically diagnosed with pathological medical conditions, were monitored closely and completed 18 days of the supplement program. Subject #8 was a 65-yr. old female with conditions indicating metal poisoning. Subject #9 was a 40 yr. old female diagnosed with chronic fatigue syndrome. Although she had undergone medical tests such as MRI and routine blood tests, the origin of her chronic fatigue and muscle weakness was unknown. Subject #12 was a 58 yr. old female diagnosed with fibromyalgia and chronic fatigue syndrome. These subjects’ initial BTA values and other clinical diagnostic information indicated that they were more physically compromised than the other group.

All capsules administered in this study contained 250 mg of naturally occurring food grade silicon dioxide, potassium, magnesium sulfate and fatty acids developed by a proprietary process in a base of rice powder and were made available by RBC Life Sciences, Inc. of Dallas, Texas as its product Microhydrin™. The instrument utilized for biological fluid analysis was a BTA S-2000™ produced by Biological Technologies International, Payson, Arizona. Blood was drawn from subjects using a non-heparin syringe and assayed within 2 minutes. Other fluids were collected and subjected to analysis according to the procedure described in the BTA S-2000 instruction manual.

Table 1
Average Changes and Statistical Data for 8 Healthy Normals
Before and After 18 Days of Supplementation


% Change

Unit Change

Mean + SD


p value

Blood pH 0.94 0.07 -0.0337 ± 0.0855 0.0229 0.1833
Saliva pH 4.10 0.29 -0.2488 ± 0.3056 0.0817 0.0187*
Urine pH 11.70 0.65 0.2588 ± 0.8848 0.2365 0.3101
Blood rH2 0.88 0.20 -0.0250 ± 0.2188 0.0585 0.6818
Saliva rH2 2.84 0.70 -0.6125 ± 0.6813 0.1821 0.0120*
Urine rH2 5.92 1.26 0.6125 ± 1.8849 0.5037 0.2634
Blood r 19.10 52.00 -34.1250 ± 52.8100 14.1164 0.0462*
Saliva r 23.80 53.60 -29.3750 ± 54.3980 14.5383 0.0830
Urine r 24.70 64.00 -17.5000 ± 22.6337 6.0491 0.0232*

*Statistically significant difference from baseline value within group (p < 0.05), using student t test for a small sample group. Abbreviations: rH2, reduction/oxidation value measured in millivolts, Barr scale; r, resistivity value measured in ohms cm; pH = -log 10-7 [H+] Values are means ± Standard Deviation (SD), Standard Error (SE)

 © 2006, RBC Life Sciences, Inc. | PRIVACY POLICY